Gene · 8519
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell Transcriptome Atlas of Newcastle Disease Virus in Chickens Both In Vitro and In Vivo. | Microbiol Spectr | 2023 | 37191506 | PubTator, text mining | PubMed |
Prolonged Primary Rhinovirus Infection of Human Nasal Epithelial Cells Diminishes the Viral Load of Secondary Influenza H3N2 Infection via the Antiviral State Mediated by RIG-I and Interferon-Stimulated Genes. | Cells | 2023 | 37190061 | PubTator, text mining | PubMed |
| Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines. | Sci Rep | 2023 | 37185361 | PubTator, text mining | PubMed |
| Dissecting Rubella Placental Infection in an In Vitro Trophoblast Model. | Int J Mol Sci | 2023 | 37175600 | PubTator, text mining | PubMed |
| Integrated interactome and transcriptome analysis reveals key host factors critical for SARS-CoV-2 infection. | Virol Sin | 2023 | 37169126 | PubTator, text mining | PubMed |
| Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles. | Front Neurol | 2023 | 37168665 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response. | JCI Insight | 2023 | 37154158 | PubTator, text mining | PubMed |
| Single-cell profiling of peripheral blood and muscle cells reveals inflammatory features of juvenile dermatomyositis. | Front Cell Dev Biol | 2023 | 37152289 | PubTator, text mining | PubMed |
| Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. | Clin Immunol | 2023 | 37150240 | PubTator, text mining | PubMed |
| Utero-ovarian low grade endometrial stromal sarcoma, a case report. | Int J Surg Case Rep | 2023 | 37148730 | PubTator, text mining | PubMed |
| Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis. | Sci Immunol | 2023 | 37146127 | PubTator, text mining | PubMed |
| Thymus antibody-secreting cells: once forgotten but not lost. | Front Immunol | 2023 | 37122712 | PubTator, text mining | PubMed |
| Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19. | Clin Immunol | 2023 | 37119951 | PubTator, text mining | PubMed |
| Effects of Betulinic Acid on the Proliferation, Cellular Senescence, and Type 1 Interferon-Related Signaling Pathways in Human Dermal Fibroblasts. | J Agric Food Chem | 2023 | 37116884 | PubTator, text mining | PubMed |
| Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy. | Viruses | 2023 | 37112989 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19. | Viruses | 2023 | 37112851 | PubTator, text mining | PubMed |
| IFITM2 Presents Antiviral Response through Enhancing Type I IFN Signaling Pathway. | Viruses | 2023 | 37112847 | PubTator, text mining | PubMed |
| Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity. | Pathogens | 2023 | 37111405 | PubTator, text mining | PubMed |
| HIV Infection Elicits Differential Transcriptomic Remodeling in CD4+ T Cells with Variable Proliferative Responses to the T Cell Receptor Stimulus. | Pathogens | 2023 | 37111397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8519/papers?page=20